Korro Bio, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2020 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Korro Bio, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2020 to Q2 2024.
- Korro Bio, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $30K, a 11.1% increase year-over-year.
- Korro Bio, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $47K, a 104% increase year-over-year.
- Korro Bio, Inc. annual Income Tax Expense (Benefit) for 2023 was $27K, a 170% increase from 2022.
- Korro Bio, Inc. annual Income Tax Expense (Benefit) for 2022 was $10K, a 33.3% decline from 2021.
- Korro Bio, Inc. annual Income Tax Expense (Benefit) for 2021 was $15K, a 57.1% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)